Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 1,962 | reported | 02 Jan 2026 | tx 365+534,227−650,068 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 155 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,962 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 166 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,958 | 0.00 USD | deriv |
| 23 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,707 | 625.60 USD | |
| 23 Jan 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 2,707 | 950.00 USD | |
| 23 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,707 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 135 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,607 | 0.00 USD | deriv |
| 06 Feb 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,613 | 482.68 USD | |
| 06 Feb 2023 | SALE | REGENERON PHARMACEUTICALS, INC. | 3,613 | 800.00 USD | |
| 06 Feb 2023 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,613 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 165 | 0.00 USD | |
| 03 Jan 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,929 | 0.00 USD | deriv |
| 30 Mar 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,431 | 374.12 USD | |
| 30 Mar 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 2,431 | 700.00 USD | |
| 30 Mar 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,431 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 191 | 0.00 USD | |
| 03 Jan 2022 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2,707 | 0.00 USD | deriv |
| 10 Sept 2021 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,479 | 380.95 USD | |
| 10 Sept 2021 | SALE | REGENERON PHARMACEUTICALS, INC. | 2,479 | 650.00 USD | |
| 10 Sept 2021 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,479 | 0.00 USD | deriv |
| 07 Jun 2021 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,930 | 374.12 USD | |
| 07 Jun 2021 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,930 | 525.00 USD | |
| 07 Jun 2021 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,930 | 0.00 USD | deriv |